메뉴 건너뛰기




Volumn 16, Issue 5, 2002, Pages 431-432

New treatments in scleroderma: The rheumatologic perspective

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIBODY; ANTIFIBROTIC AGENT; BOSENTAN; COLLAGEN TYPE 1; CYCLOPHOSPHAMIDE; ILOPROST; IMMUNOGLOBULIN G4; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLAMINE; PROSTAGLANDIN E1; PROSTANOID; RELAXIN; THALIDOMIDE; THYMOCYTE ANTIBODY;

EID: 0036749714     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2002.00551.x     Document Type: Editorial
Times cited : (3)

References (17)
  • 1
    • 0010992846 scopus 로고    scopus 로고
    • Modulation of endothelial gene expression by prostacyclin in systemic sclerosis
    • Kahaleh BM, Fan PG, Matucci Cerinic M. Modulation of endothelial gene expression by prostacyclin in systemic sclerosis. Arthritis Rheum 2000; 43 (Suppl.): 1148.
    • (2000) Arthritis Rheum , vol.43 , Issue.SUPPL. , pp. 1148
    • Kahaleh, B.M.1    Fan, P.G.2    Matucci Cerinic, M.3
  • 2
    • 0034997698 scopus 로고    scopus 로고
    • Novel mode of action of iloprost: In vitro down-regulation of endothelial cell adhesion molecules
    • Della Bella S, Molteni M, Macellini C et al. Novel mode of action of iloprost:in vitro down-regulation of endothelial cell adhesion molecules. Prostaglandins 2001; 65: 73-83.
    • (2001) Prostaglandins , vol.65 , pp. 73-83
    • Della Bella, S.1    Molteni, M.2    Macellini, C.3
  • 3
    • 0010956423 scopus 로고    scopus 로고
    • PGE1 restores the circulating levels of vWF and ACE and modulates the levels of adhesion molecules in SSc
    • Angotti C, Matucci Cerinic M, Kalfin R et al. PGE1 restores the circulating levels of vWF and ACE and modulates the levels of adhesion molecules in SSc. Arthritis Rheum 2000; 43 (Suppl.): 1166.
    • (2000) Arthritis Rheum , vol.43 , Issue.SUPPL. , pp. 1166
    • Angotti, C.1    Matucci Cerinic, M.2    Kalfin, R.3
  • 4
    • 0034837756 scopus 로고    scopus 로고
    • Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud's phenomenon. A randomized controlled study
    • Scorza R, Caronni M, Mascagni B et al. Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud's phenomenon. A randomized controlled study. Clin Exp Rheumatol 2001; 19: 503-508.
    • (2001) Clin. Exp. Rheumatol , vol.19 , pp. 503-508
    • Scorza, R.1    Caronni, M.2    Mascagni, B.3
  • 5
    • 0034743786 scopus 로고    scopus 로고
    • Prostaglandin E1 restores the levels of vWF and ACE in chronic critical limb ischemia in systemic sclerosis
    • Pignone A, Generini S, Matucci Cerinic M. Prostaglandin E1 restores the levels of vWF and ACE in chronic critical limb ischemia in systemic sclerosis. Clin Exp Rheumatol 2001; 19: 358-359.
    • (2001) Clin. Exp. Rheumatol , vol.19 , pp. 358-359
    • Pignone, A.1    Generini, S.2    Matucci Cerinic, M.3
  • 6
    • 0035818316 scopus 로고    scopus 로고
    • Effects of dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomized placebo-controlled study
    • Channick RN, Simonneau G, Rubin JL et al. Effects of dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study. Lancet 2001; 358: 1119-1123.
    • (2001) Lancet , vol.358 , pp. 1119-1123
    • Channick, R.N.1    Simonneau, G.2    Rubin, J.L.3
  • 7
    • 0035098516 scopus 로고    scopus 로고
    • The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis
    • Herrick N, Matucci Cerinic M. The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol 2001; 19: 4-8.
    • (2001) Clin. Exp. Rheumatol , vol.19 , pp. 4-8
    • Herrick, N.1    Matucci Cerinic, M.2
  • 8
    • 0034789303 scopus 로고    scopus 로고
    • Intravenous N-Acetylcisteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: A Pilot study
    • Sambo P, Amico D et al, Intravenous N-Acetylcisteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a Pilot study. J Rheumatol 2001; 28: 2257-2262.
    • (2001) J. Rheumatol , vol.28 , pp. 2257-2262
    • Sambo, P.1    Amico, D.2
  • 9
    • 0033769659 scopus 로고    scopus 로고
    • Immune stimulation in scleroderma patients treated with thalidomide
    • Oliver SJ, Moreira A, Kaplan G. Immune stimulation in scleroderma patients treated with thalidomide. Clin Immunol 2000; 97: 109-120.
    • (2000) Clin. Immunol , vol.97 , pp. 109-120
    • Oliver, S.J.1    Moreira, A.2    Kaplan, G.3
  • 10
    • 15644364960 scopus 로고    scopus 로고
    • Type 2 helper T cell predominance and high CD30 expression in systemic sclerosis
    • Mavilia C, Scaletti C, Romagnani P et al. Type 2 helper T cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 1997; 151: 1751-1758.
    • (1997) Am. J. Pathol , vol.151 , pp. 1751-1758
    • Mavilia, C.1    Scaletti, C.2    Romagnani, P.3
  • 11
    • 0035144259 scopus 로고    scopus 로고
    • Pilot study of anti-thymocite globulin plus micophenolate mofetil in recent onset diffuse scleroderma
    • Stratton RJ, Wilson H, Black CM. Pilot study of anti-thymocite globulin plus micophenolate mofetil in recent onset diffuse scleroderma. Rheumatology 2001; 40: 84-88.
    • (2001) Rheumatology , vol.40 , pp. 84-88
    • Stratton, R.J.1    Wilson, H.2    Black, C.M.3
  • 12
    • 0034121227 scopus 로고    scopus 로고
    • Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen
    • McKown Carbone LD, Postlethwaite AE et al. Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen. Arthritis Rheum 2000; 43:1054-1061.
    • (2000) Arthritis Rheum , vol.43 , pp. 1054-1061
    • McKown Carbone, L.D.1    Postlethwaite, A.E.2
  • 13
    • 0034691244 scopus 로고    scopus 로고
    • Cyclophosphamide seems associated with pulmonary function and survival benefits in patients with scleroderma and alveolitis
    • White B, Moore WC, Wigley FM et al. Cyclophosphamide seems associated with pulmonary function and survival benefits in patients with scleroderma and alveolitis. Ann Intern Med 2000; 132: 947-954.
    • (2000) Ann. Intern. Med , vol.132 , pp. 947-954
    • White, B.1    Moore, W.C.2    Wigley, F.M.3
  • 14
    • 0036225585 scopus 로고    scopus 로고
    • Cyclophosphamide Pulse Regimen in the treatment of Alveolitis in Systemic Sclerosis
    • Giacomelli R, Valentini G, Salsano F et al. Cyclophosphamide Pulse Regimen in the treatment of Alveolitis in Systemic Sclerosis. J Rheumatol 2002; 29: 731-736.
    • (2002) J. Rheumatol , vol.29 , pp. 731-736
    • Giacomelli, R.1    Valentini, G.2    Salsano, F.3
  • 15
    • 0030941193 scopus 로고    scopus 로고
    • Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit
    • Jerster JV, Bany-Lane PA, Petroll WM et al. Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit. Cornea 1997; 16: 177-187.
    • (1997) Cornea , vol.16 , pp. 177-187
    • Jerster, J.V.1    Bany-Lane, P.A.2    Petroll, W.M.3
  • 16
    • 0033571072 scopus 로고    scopus 로고
    • Anti TGFβ tratments prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: A model for human scleroderma
    • McCormick LL, Zhang Y, Tootell E, Gilliam Al. Anti TGFβ tratments prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 1999; 163: 5693-5699.
    • (1999) J. Immunol , vol.163 , pp. 5693-5699
    • McCormick, L.L.1    Zhang, Y.2    Tootell, E.3    Gilliam, Al.4
  • 17
    • 0035017415 scopus 로고    scopus 로고
    • Phase I/II trial of autologous stem cell transplantion in systemic sclerosis: Procedure related mortality and impact on skin disease
    • Binks M, Passweg JR, Furst D, et al. Phase I/II trial of autologous stem cell transplantion in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis 2001; 60: 577-584.
    • (2001) Ann. Rheum. Dis , vol.60 , pp. 577-584
    • Binks, M.1    Passweg, J.R.2    Furst, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.